Beone Medicines USA
Beone Medicines USA has no reported trades by members of Congress since 2025. Spent $1.1M on lobbying.
- Members trading it
- 0
- Trades since 2025
- 0
- Lobbying spend
- $1.1M
- Employees
- 16,000
Lobbying and PAC
Former congressional staff lobbying for it
- Matthew LeffingwellMbr Servs & Coalitions Dir., House Approps Cmte (2016-2017); CoS, Rep. Kay Granger (2012-2015); Dep CoS, Rep.
More
From House and Senate stock trade disclosures, USAspending.gov, lobbying reports and FEC records.
Cite or embed this page
Capitol Receipts, “Beone Medicines USA: Congress Stock Trades & Lobbying,” https://www.capitolreceipts.com/company/beone-medicines/beone-medicines-usa (accessed 2026-10-16).